| The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment M Farhad, AS Rolig, WL Redmond Oncoimmunology 7 (6), e1434467, 2018 | 163 | 2018 |
| Individual members of the microbiota disproportionately modulate host innate immune responses AS Rolig, R Parthasarathy, AR Burns, BJM Bohannan, K Guillemin Cell host & microbe 18 (5), 613-620, 2015 | 151 | 2015 |
| The enteric nervous system promotes intestinal health by constraining microbiota composition AS Rolig, EK Mittge, J Ganz, JV Troll, E Melancon, TJ Wiles, K Alligood, ... PLoS biology 15 (2), e2000689, 2017 | 145 | 2017 |
| Kv2. 1 potassium channels are retained within dynamic cell surface microdomains that are defined by a perimeter fence KMS O'Connell, AS Rolig, JD Whitesell, MM Tamkun Journal of Neuroscience 26 (38), 9609-9618, 2006 | 141 | 2006 |
| Interhost dispersal alters microbiome assembly and can overwhelm host innate immunity in an experimental zebrafish model AR Burns, E Miller, M Agarwal, AS Rolig, K Milligan-Myhre, S Seredick, ... Proceedings of the National Academy of Sciences 114 (42), 11181-11186, 2017 | 136 | 2017 |
| A cytoskeletal-based perimeter fence selectively corrals a sub-population of cell surface Kv2. 1 channels MM Tamkun, KMS O'connell, AS Rolig Journal of cell science 120 (14), 2413-2423, 2007 | 109 | 2007 |
| Spatial and temporal features of the growth of a bacterial species colonizing the zebrafish gut M Jemielita, MJ Taormina, AR Burns, JS Hampton, AS Rolig, K Guillemin, ... MBio 5 (6), 10.1128/mbio. 01751-14, 2014 | 104 | 2014 |
| The degree of Helicobacter pylori-triggered inflammation is manipulated by preinfection host microbiota AS Rolig, C Cech, E Ahler, JE Carter, KM Ottemann Infection and immunity 81 (5), 1382-1389, 2013 | 90 | 2013 |
| Helicobacter pylori requires TlpD-driven chemotaxis to proliferate in the antrum AS Rolig, J Shanks, JE Carter, KM Ottemann Infection and immunity 80 (10), 3713-3720, 2012 | 85 | 2012 |
| Bacterial chemotaxis modulates host cell apoptosis to establish a T-helper cell, type 17 (Th17)-dominant immune response in Helicobacter pylori infection AS Rolig, JE Carter, KM Ottemann Proceedings of the National Academy of Sciences 108 (49), 19749-19754, 2011 | 61 | 2011 |
| A bacterial immunomodulatory protein with lipocalin-like domains facilitates host–bacteria mutualism in larval zebrafish AS Rolig, EG Sweeney, LE Kaye, MD DeSantis, A Perkins, AV Banse, ... Elife 7, e37172, 2018 | 59 | 2018 |
| Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor BD Curti, Y Koguchi, RS Leidner, AS Rolig, ER Sturgill, Z Sun, Y Wu, ... Journal for immunotherapy of cancer 9 (4), 2021 | 52 | 2021 |
| Galectin-3 inhibition with belapectin combined with anti-OX40 therapy reprograms the tumor microenvironment to favor anti-tumor immunity ER Sturgill, AS Rolig, SN Linch, C Mick, MJ Kasiewicz, Z Sun, PG Traber, ... Oncoimmunology 10 (1), 1892265, 2021 | 29 | 2021 |
| NKTR-214 immunotherapy synergizes with radiotherapy to stimulate systemic CD8+ T cell responses capable of curing multi-focal cancer JM Walker, AS Rolig, DH Charych, U Hoch, MJ Kasiewicz, DC Rose, ... Journal for immunotherapy of cancer 8 (1), 2020 | 21 | 2020 |
| Combining bempegaldesleukin (CD122-preferential IL-2 pathway agonist) and NKTR-262 (TLR7/8 agonist) improves systemic antitumor CD8+ T cell cytotoxicity over BEMPEG+ RT AS Rolig, DC Rose, GH McGee, W Rubas, S Kivimäe, WL Redmond Journal for Immunotherapy of Cancer 10 (4), 2022 | 16 | 2022 |
| Spatial and temporal features of the growth of a bacterial species colonizing the zebrafish gut. mBio 5: e01751-14 M Jemielita, MJ Taormina, AR Burns, JS Hampton, AS Rolig, K Guillemin, ... December, 2014 | 12 | 2014 |
| Arginase therapy combines effectively with immune checkpoint blockade or agonist anti-OX40 immunotherapy to control tumor growth MD Badeaux, AS Rolig, G Agnello, D Enzler, MJ Kasiewicz, L Priddy, ... Cancer Immunology Research 9 (4), 415-429, 2021 | 11 | 2021 |
| Intratumoral electroporation of plasmid encoded IL12 and membrane-anchored anti-CD3 increases systemic tumor immunity M Han, B Nguyen, JY Lee, E Browning, J Zhang, A Mukhopadhyay, ... Molecular Cancer Research 20 (6), 983-995, 2022 | 9 | 2022 |
| Enhancing the Generation of Eomeshi CD8+ T Cells Augments the Efficacy of OX40- and CTLA-4–Targeted Immunotherapy DA Emerson, AS Rolig, WL Redmond Cancer Immunology Research 9 (4), 430-440, 2021 | 9 | 2021 |
| The role of galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment. OncoImmunology 7, e1434467 M Farhad, AS Rolig, WL Redmond | 8 | 2018 |
William L. RedmondMember (Full Professor), Earle A. Chiles Research Institute, Providence Cancer InstituteDirección de correo verificada de providence.org
